- GlobeNewswire•13 days ago
HAYWARD, Calif., Aug. 16, 2016-- Anthera Pharmaceuticals, Inc. today announced the appointment of William Shanahan, M.D., J.D. as Chief Medical Officer. In his role as Chief Medical Officer, Dr. Shanahan ...
- 24/7 Wall St.•13 days ago
On Tuesday, a few biotech companies made substantial runs, either up and down, due to the results of FDA approvals, failed or passed trials and even earnings results.
Anthera Pharmaceuticals, Inc. (ANTH)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Bid||2.95 x 100|
|Ask||3.01 x 100|
|Day's Range||2.90 - 3.01|
|52wk Range||2.28 - 10.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-2.69|
|Avg Vol (3m)||529,780|
|Dividend & Yield||N/A (N/A)|